ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →

Thursday, 12 November 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Marksans Pharma Ltd

NSE: MARKSANS · BSE: 524404 · Pharmaceuticals & Biotechnology · 37 announcements

Share price: ₹306.55
Market cap: ₹13,893 Cr
Revenue (annual): ₹2,951 Cr
Net profit (annual): ₹417.9 Cr
P/E (TTM): 24.8×Sector 43.8×
Promoter holding: 43.87%+0.00% QoQ
FII holding: 19.06%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 2 Results Update 1 Other Announcement 1 Financial Results 1 Employee Stock Options 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

4 Nov 2026 13:27 IST BSE

Financial Results

Marksans Pharma Q2 FY27 Results: Net Profit ₹143.5 Cr, Up 44.8% YoY

Marksans Pharma Ltd reported revenue from operations of ₹940.2 Cr (+30.5% YoY) and net profit of ₹143.5 Cr (+44.8% YoY) for Q2 FY27.

Key figure: Net profit ₹143.5 Cr · +44.8% YoY

Open full results → Read the filing ↗

Marksans Pharma Ltd by type